RANCHO CUCAMONGA, CA / ACCESS Newswire / February 24, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the ...
DUBLIN--(BUSINESS WIRE)--The "Drug Overview: Trelegy Ellipta" report has been added to ResearchAndMarkets.com's offering. Trelegy Ellipta ([fluticasone furoate + vilanterol + umeclidinium bromide]; ...
So many people are taking bromides on their own account, so many doctors are prescribing bromides for their nervous patients, that bromide intoxication has become comparatively frequent. Last week the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results